Serratus Plane Block Versus Serratus Plane Block Plus Parasternal Block Combination for Breast Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-21

Study Completion Date

2024-01-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Mastectomy is a technique often used in breast cancer surgery. Patients experience moderate to severe pain postoperatively after this procedure. Various plane blocks, NSAIDs, and opioid analgesics can be administered to these patients as components of multimodal analgesia. In the the study, the investigators aimed to evaluate the analgesic effects of the serratus plane block, the parasternal block added to the serratus plane block, and the dermatomal differences.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of Postoperative Analgesic Effectiveness of Superficial and Deep Serratus Plane Blocks for Mastectomy

NCT06438211

Mastectomy Postoperative Pain Analgesia

COMPLETED NA

Serratus Plane Plus Pectoral I Block Versus Serratus Plane Block for Perioperative Analgesia in Breast Cancer Surgery

NCT03899545

Postoperative Pain Postoperative Nausea Patient Satisfaction +1 more

COMPLETED NA

Superficial Serratus Plane Block for Modified Radical Mastectomy and Axillary Lymph Node Disection

NCT03341234

Postoperative Analgesia Pain, Postoperative Opioid Consumption

COMPLETED NA

SPSIPB for Breast Cancer Surgery

NCT06225908

Pain, Postoperative Pain, Acute Opioid Consumption

COMPLETED NA

Efficacy of Serratus Posterior Intercostal Plane Block for Analgesia and Inflammatory Marker in Breast Surgery

NCT06502067

Breastcancer Perioperative Pain Inflammation

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Analgesia Cancer, Breast

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group serratus

preoperative superficial serratus block with local anaesthetics and parasternal block with saline

Group Type PLACEBO_COMPARATOR

group serratus plan block

Intervention Type OTHER

preoperativelly, Superficial Serratus Block performed with 30 ml %0.25 Bupivacaine and Parasternal Block performed with 10 ml saline

group serratus and parasternal

preoperative superficial serratus block and parasternal block with local anaesthetics

Group Type ACTIVE_COMPARATOR

group serratus and parasternal plan block

Intervention Type OTHER

preoperativelly, Superficial Serratus Block performed with 30 ml %0.25 Bupivacaine and Parasternal Block performed with 10 ml %0.25 Bupivacaine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

group serratus plan block

preoperativelly, Superficial Serratus Block performed with 30 ml %0.25 Bupivacaine and Parasternal Block performed with 10 ml saline

Intervention Type OTHER

group serratus and parasternal plan block

preoperativelly, Superficial Serratus Block performed with 30 ml %0.25 Bupivacaine and Parasternal Block performed with 10 ml %0.25 Bupivacaine

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. American Society of Anesthesiologist's physiologic state I-III patients
2. To undergo Mastectomy Surgery
3. Being between the ages of 18-65 years

Exclusion Criteria

* Having a known heart, kidney, liver or hematological disease
* Having a history of peptic ulcer, gastrointestinal bleeding, allergy, chronic pain
* Routine analgesic use and history of analgesic use in the last 24 hours
* Not willing to participate in the study
* Uncooperative patients who have coagulopathy or use anticoagulant drugs
* To be allergic to one of the drugs to be used

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No